160 related articles for article (PubMed ID: 38159594)
1. The role of Keap1-Nrf2 signaling pathway during the progress and therapy of diabetic retinopathy.
Chen J; Wang Q; Li R; Li Z; Jiang Q; Yan F; Ye J
Life Sci; 2024 Feb; 338():122386. PubMed ID: 38159594
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy.
Zhong Q; Mishra M; Kowluru RA
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3941-8. PubMed ID: 23633659
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA
Radhakrishnan R; Kowluru RA
Diabetes; 2021 Jan; 70(1):227-239. PubMed ID: 33051272
[TBL] [Abstract][Full Text] [Related]
4. Astaxanthin inhibits oxidative stress and apoptosis in diabetic retinopathy.
Fang J; Bai W; Yang L
Acta Histochem; 2023 Aug; 125(6):152069. PubMed ID: 37343496
[TBL] [Abstract][Full Text] [Related]
5. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.
Kowluru RA; Mishra M
Free Radic Biol Med; 2017 Feb; 103():155-164. PubMed ID: 28012783
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway.
Liu Y; Wang S; Jin G; Gao K; Wang S; Zhang X; Zhou K; Cai Y; Zhou X; Zhao Z
Phytomedicine; 2023 Sep; 118():154915. PubMed ID: 37392674
[TBL] [Abstract][Full Text] [Related]
9. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy.
Adelusi TI; Du L; Hao M; Zhou X; Xuan Q; Apu C; Sun Y; Lu Q; Yin X
Biomed Pharmacother; 2020 Mar; 123():109732. PubMed ID: 31945695
[TBL] [Abstract][Full Text] [Related]
10. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
[TBL] [Abstract][Full Text] [Related]
11. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
12. The Nrf2 activator MIND4-17 protects retinal ganglion cells from high glucose-induced oxidative injury.
Chen N; Li Y; Huang N; Yao J; Luo WF; Jiang Q
J Cell Physiol; 2020 Oct; 235(10):7204-7213. PubMed ID: 32020639
[TBL] [Abstract][Full Text] [Related]
13. Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling.
Kaur G; Sharma A; Bhatnagar A
Autoimmunity; 2021 Nov; 54(7):385-397. PubMed ID: 34415206
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
[TBL] [Abstract][Full Text] [Related]
15. Hedysarum polysaccharide alleviates oxidative stress to protect against diabetic peripheral neuropathy via modulation of the keap1/Nrf2 signaling pathway.
He L; Huan P; Xu J; Chen Y; Zhang L; Wang J; Wang L; Jin Z
J Chem Neuroanat; 2022 Dec; 126():102182. PubMed ID: 36334786
[TBL] [Abstract][Full Text] [Related]
16. The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism.
Song MY; Lee DY; Chun KS; Kim EH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922165
[TBL] [Abstract][Full Text] [Related]
17. Formononetin, a bioactive isoflavonoid constituent from Astragalus membranaceus (Fisch.) Bunge, ameliorates type 1 diabetes mellitus via activation of Keap1/Nrf2 signaling pathway: An integrated study supported by network pharmacology and experimental validation.
Chen H; Lou Y; Lin S; Tan X; Zheng Y; Yu H; Jiang R; Wei Y; Huang H; Qi X; Zhang R; Liu Z; Wu J
J Ethnopharmacol; 2024 Mar; 322():117576. PubMed ID: 38104880
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
[TBL] [Abstract][Full Text] [Related]
19. Keap1/Nrf2/HO-1 signaling pathway contributes to p-chlorodiphenyl diselenide antidepressant-like action in diabetic mice.
Zborowski VA; Heck SO; Vencato M; Pinton S; Marques LS; Nogueira CW
Psychopharmacology (Berl); 2020 Feb; 237(2):363-374. PubMed ID: 31828396
[TBL] [Abstract][Full Text] [Related]
20. Keap1-Nrf2 signaling pathway in angiogenesis and vascular diseases.
Guo Z; Mo Z
J Tissue Eng Regen Med; 2020 Jun; 14(6):869-883. PubMed ID: 32336035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
